Gore S M, Bird A G, Burns S M, Goldberg D J, Ross A J, Macgregor J
MRC Biostatistics Unit, Institute of Public Health, Cambridge.
BMJ. 1995 Feb 4;310(6975):293-6. doi: 10.1136/bmj.310.6975.293.
To determine prevalence of HIV infection and drug injecting behaviour among inmates of Glenochil Prison on a specified date a year after an outbreak of hepatitis B and HIV infection.
Cross sectional: voluntary, anonymous HIV salivary antibody surveillance and linked self completion questionnaire on risk factors.
Glenochil prison, Scotland, a year after an outbreak of hepatitis B and HIV transmission related to drug injection.
352 prisoners, of whom 295 (84%) took part; 284 questionnaires (96%) passed logical checks.
HIV prevalence; proportion of all inmates who had ever injected drugs, had ever injected inside prison, had started injecting drugs while inside prison.
More than half (150/284) the current inmates were also in Glenochil Prison during the critical period of January to June 1993, when hepatitis B and HIV were transmitted. Similar proportions of current inmates and men who were also in Glenochil during the critical period were drug users (27% (75/278) v 30% (44/149)). A quarter of injecting drug users (18/72) had first injected inside prison, irrespective of whether they were in Glenochil in January to June 1993 and regardless of the calendar period when they first injected. Significantly more inmates from Glasgow (41%; 56/138) than from Edinburgh (21%; 7/34) or elsewhere (11%; 12/106) were injecting drug users. On testing for HIV, seven saliva samples out of 293 gave positive results--four were presumed to be from inmates known to be infected with HIV, and the others from injecting drug users from Glasgow, all of whom had been in Glenochil during January to June 1993, when two of the three had injected drugs and had been tested for HIV, with negative results. The ratio of overall (2.4%) to disclosed (1.4%) HIV prevalence was 1.7. For men who had injected drugs in Glenochil during January to June 1993, HIV prevalence was estimated at 29%.
Between a quarter and a third of prisoners who injected drugs in Glenochil in January to June 1993 were infected with HIV. There is widespread ongoing risk of bloodborne virus infection within prisons, which is probably long standing but demands urgent attention.
确定在乙型肝炎和艾滋病毒感染暴发一年后的特定日期,格莱诺基尔监狱囚犯中艾滋病毒感染率及药物注射行为情况。
横断面研究:自愿、匿名的艾滋病毒唾液抗体监测及相关危险因素自填问卷。
苏格兰格莱诺基尔监狱,在与药物注射相关的乙型肝炎和艾滋病毒传播暴发一年后。
352名囚犯,其中295人(84%)参与;284份问卷(96%)通过逻辑检查。
艾滋病毒感染率;曾注射过毒品、曾在监狱内注射、在监狱内开始注射毒品的所有囚犯比例。
超过半数(150/284)的现囚犯在1993年1月至6月的关键时期也在格莱诺基尔监狱,当时乙型肝炎和艾滋病毒发生了传播。现囚犯与在关键时期也在格莱诺基尔监狱的男性中吸毒者比例相似(27%(75/278)对30%(44/149))。四分之一的注射吸毒者(18/72)首次在监狱内注射,无论他们在1993年1月至6月是否在格莱诺基尔监狱,也无论他们首次注射的日历时间段。来自格拉斯哥的囚犯(41%;56/138)中注射吸毒者显著多于来自爱丁堡(21%;7/34)或其他地方(11%;12/106)的囚犯。在进行艾滋病毒检测时,293份唾液样本中有7份呈阳性结果——4份推测来自已知感染艾滋病毒的囚犯,其他来自格拉斯哥的注射吸毒者,他们在1993年1月至6月期间都在格莱诺基尔监狱,其中三人中有两人在此期间注射过毒品并接受过艾滋病毒检测,结果为阴性。总体艾滋病毒感染率(2.4%)与已披露感染率(1.4%)之比为1.7。对于在1993年1月至6月期间在格莱诺基尔监狱注射过毒品的男性,艾滋病毒感染率估计为29%。
1993年1月至6月在格莱诺基尔监狱注射毒品的囚犯中有四分之一到三分之一感染了艾滋病毒。监狱内血源性病毒感染风险广泛存在且持续,可能由来已久但亟待关注。